Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
No significant weight loss occurs in cambinol-treated animals relative to controls
7S)-N-tert-butyl-3-(2
S55746 hydrochloride (BCL201 hydrochloride) has antitumor activity with low toxicity
protects rat myocardium-derived H9C2 cells against apoptosis
Ranolazine-d8 H-PEG4-CH2COOH No significant weight loss occursRanolazine d8 (CVT 303 d8) is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 M and 12 M, respectively) without affecting heart rate or blood pressure (BP). Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor. Antianginal agent. Product information CAS Number: 1092804 88 0 Molecular Weight: 435.
US$ 1347.43
US$ 1062.35
US$ 6658.02
US$ 2181.54
US$ 3360.37